Phase 2, randomised placebo-controlled trial to evaluate the efficacy and safety of an anti-GM-CSF antibody (KB003) in patients with inadequately controlled asthma

OBJECTIVES: We wished to evaluate the effects of an antigranulocyte-macrophage colony-stimulating factor monoclonal antibody (KB003) on forced expiratory volume in 1 s (FEV(1)), asthma control and asthma exacerbations in adult asthmatics inadequately controlled by long-acting bronchodilators and inh...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:BMJ Open
Main Authors: Molfino, Nestor A, Kuna, Piotr, Leff, Jonathan A, Oh, Chad K, Singh, Dave, Chernow, Marlene, Sutton, Brian, Yarranton, Geoffrey
Format: Artigo
Sprog:Inglês
Udgivet: BMJ Publishing Group 2016
Fag:
Respiratory Medicine
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC4716197/
https://ncbi.nlm.nih.gov/pubmed/26739717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2015-007709
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker